People of color, women, and those with health conditions are among at the highest risk.
Faith leaders help recruit people of color for a new nationwide study.
Study of vaccinated cancer patients with breakthrough COVID-19 shows 13% mortality rate.
Researchers develop an RNA-based breath test to detect SARS-CoV-2.
New methods allow for a better understanding of how genetic conditions affect different populations.
Led by Brown, a multi-university effort will build on recent discoveries about the mechanisms of aging.
In managed care plans, minority group members report lesser care than white enrollees.
Researchers develop new model to investigate fibrosis treatments without use of animals.
Brown senior studies the neurobiological underpinnings of alcohol and substance abuse disorders with the goal of enabling more effective treatments.
Investigators partner with faith-based leaders in Providence to increase participation of Black community members in prevention studies.
Even those who are fully vaccinated have high rates of hospitalization and death with breakthrough infections.
‘The Bubbler’ reverse-transcribes RNA from airborne SARS-CoV-2, researchers say.
Generous support from the Legorreta family will accelerate discovery of new treatments for patients.
People of color, women, and those with health conditions are most likely to experience hardship.
Cellular mechanism explains behind why some are at greater risk, and may be used to protect them.
Renewed NIH grant helps researchers and local partners address barriers to testing and vaccination.
The Medical School and School of Public Health launch an initiative to study long-term effects of COVID-19.
Transposons play a significant role in aging and disease, researcher says.
Five-year, $19.9M grant to Advance-CTR will support scientists in taking their work from bench to bedside to the people of…
A global EM fellow studying emergency medicine in Nepal immerses himself in the practice.
A long-term study engages Rhode Island families in research that may help countless children.
New report puts post-vaccine risk in perspective.
With $30 million in support, the center aims to accelerate the pace of development for novel treatments and cures.
The gene editing technology can help reveal secrets of the brain’s function and role in disease.
